BioNexus Gene Lab Corp
For the period ended Jun 30, 2024. Filed Aug 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 14, 2024
BGLC$0.83-3.1%Stored close · as of Nov 6, 2026
What changed in Risk Factors?
Read the current filingComparison unavailable
We could not identify this Item in the current filing’s readable text.
Earlier comparable report: 10-Q, period ended 2024-03-31, filed 2024-05-15. Read that report
Unavailable is not the same as unchanged.